Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-10-28
1999-08-03
Stockton, Laura L.
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
546 48, 546 92, 546141, 546 15, 548492, C07D49120, C07D49122
Patent
active
059327324
ABSTRACT:
A process for preparing S type 2-substituted hydroxy-2-indolidinyl-butyric ##STR1## wherein R.sup.o is residue of nitrogen-containing fused heterocyclic carboxylic acid having absolute configuration of "R"(in which the nitrogen atom is protected), R.sup.1 and R.sup.2 are lower alkyl group, and E is ester residue, which is useful as an intermediate for preparing camptothecin derivatives having antitumor activities, which comprises ##STR2## wherein the symbols are as defined above.
REFERENCES:
A. Ejima et al., "Antitumor Agents, Part 2. Asymmetric Synthesis of (S)-Camptothecin" No. 1, 1990, pp. 27-31, XP002010690.
E.A. Mash, S.B. Hemperly: "Mechanistic Studies of Disastereoselective Cyclopropanation via Homochiral Ketals. 2. Studies with Conformationally Restricted 2-Cyclohexene-1-one Ketals", vol. 55, No. 7, 1990, pp.2055-2060, XP002054434.
A. Ejima et al., "Asymmetric Synthesis of (S)-Camptothecin" Tetrahedron Lett, vol. 30, No. 20, 1989, pp. 2639-2640, XP002054435.
A. Ejima et al., "Antitumor Agents v. Synthesis and Antileukemic Activity of E-Ring-Modified (RS)-Camptothecin Analogues" Chem. Pharm. Bull., vol. 40, No. 3, 1992, pp. 683-688, XP000653713.
Bioorganic & Medicinal Chemistry Lettter, vol. 5, No. 24, pp. 3063-3066, 1995.
Journal of Medicinal Chemistry, 1986, vol. 29, pp. 2358-2363.
Journal of Medicinal Chemistry, 1980, vol. 23, pp. 554-560.
Journal of Medicinal Chemistry, 1991, vol. 34, pp. 98-107.
Organic Synthetic Chemistry, vol. 49, No. 11, pp. 1013-1020, 1991.
Kawaguchi Takayuki
Nomura Sumihiro
Tsujihara Kenji
Stockton Laura L.
Tanabe Seiyaku Co. Ltd.
LandOfFree
S type 2-substituted hydroxy-2-indolidinylbutyric ester compound does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with S type 2-substituted hydroxy-2-indolidinylbutyric ester compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and S type 2-substituted hydroxy-2-indolidinylbutyric ester compound will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-850650